Search results
Showing 3631 to 3645 of 8238 results
Get expert advice and support from NICE International, part of the UK's National Institute for Health and Care Excellence, for a project in your country
Our indicators measure outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.
Our quality standards set out priority areas for quality improvement in health, public health and social care.
A timeline showing where in the NICE evaluation process companies will be charged.
A step-by-step summary about how we develop our technology appraisal guidance.
Health Technology Assessment Innovation Laboratory (HTA Lab)
NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.
Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.
Ask an expert from NICE International, part of the UK's National Institute for Health and Care Excellence, to speak at a healthcare event in your country
Our role in the Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.
Home What NICE does Digital health...
Tools for building or evaluating a medtech evidence base with NICE
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies
Managed access allows people to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.
Learn from NICE International, part of the UK's National Institute for Health and Care Excellence, about how to improve your nation's health and wellbeing
This guidance evaluates digital technologies, diagnostics and medical devices (including artificial intelligence).